Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice

American Journal of Pathology

Volumn 163, Issue 4, 2003, Pages 1579-1586

  Kang, Y James ^a,b   Li, Yan ^a   Sun, Xichun ^a   Sun, Xiuhua ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOCHROME C; DIMETHYL SULFOXIDE; METALLOTHIONEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG MECHANISM; ENZYME ACTIVATION; HEART INFARCTION; HEART LEFT VENTRICLE INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; LIPID PEROXIDATION; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; TRANSGENIC MOUSE;

EID: 0141425616     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63514-6     Document Type: Article

References (35)

1. Kang YJ, Chen Y, Yu A, Voss-McCowan M, Epstein PN: Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 1997, 100:1501-1506
2. Kang YJ, Li G, Saari JT: Metallothionein inhibits ischemia-reperfusion injury in mouse heart. Am J Physiol 1999, 276:H993-H997
3. Kang YJ: The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med 1999, 222:263-273
4. Sun X, Zhou Z, Kang YJ: Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res 2001, 61:3382-3387
5. Wang GW, Klein JB, Kang YJ: Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp Ther 2001, 298:461-468
6. Kang YJ, Zhou ZX, Wang GW, Buridi A, Klein JB: Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J Biol Chem 2000, 275:13690-13698
7. Wang GW, Zhou Z, Klein JB, Kang YJ: Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes. Am J Physiol Heart Circ Physiol 2001, 280:H2292-H2299
8. Curello S, Ceconi C, de Giuli F, Panzal AF, Milanesi B, Calarco M, Pardini A, Marzollo P, Alfieri O, Messineo F, Ferrari R: Oxidative stress during reperfusion of human hearts; potential sources of oxygen free radicals. Cardiovasc Res 1995, 29:118-125
9. Jeroudi MO, Hartley CJ, Bolli R: Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidant. Am J Cardiol 1994, 73:2B-7B
10. Lucchesi BR: Myocardial ischemia, reperfusion and free radical injury. Am J Cardiol 1990, 65:141-231.
11. Fliss H, Gattinger D: Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996, 79:949-956
12. Gottlieb RA, Burleson KO, Kloner RA, Bablor BM, Engler RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994, 94:1621-1628
13. Green, DR; Reed JC: Mitochondria and apoptosis. Science 1998, 281:1309-1312
14. Higuchi M, Proske RJ, Yeh ET: Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene 1998, 17:2515-2524
15. Pan G, Humke EW, Dixit VM: Activation of caspases triggered by cytochrome c in vitro. FEBS Lett 1998, 426:151-154
16. Ma Y, Ogino T, Kawabata T, Li J, Eguchi K, Okada S: Cupric nitrilotriacetate-induced apoptosis in HL-60 cells association with lipid peroxidation, release of cytochrome c from mitochondria, and activation of caspase-3 Free Radic Biol Med 1999, 27:227-233
17. Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996, 86:147-157
18. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/ caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489
19. Jassem W, Fuggle SV, Rela M, Koo DD, Heaton ND: The role of mitochondria in ischemia/reperfusion injury. Transplantation 2002, 73:493-499
20. Palmiter RD, Sandgren EP, Koeller DM, Brinster RL: Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol Cell Biol 1993, 13:5266-5275
21. Eaton DL, Cherian MG: Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay. Methods Enzymol 1991, 205:83-88
22. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM: Myocardial ischemia and reperfusion: a murine model. Am J Physiol 1995, 269:H2147-H2154
23. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358
24. Gottlieb RA, Engler RL: Apoptosis in myocardial ischemia-reperfusion. Ann NY Acad Sci 1999, 874:412-426
25. Maulik N, Yoshida T, Das DK: Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis Free Radic Biol Med 1998, 24:869-875
26. Henry TD, Archer SL, Nelson D, Weir EK, From AH: Enhanced chemiluminescence as a measure of oxygen-derived free radical generation during ischemia and reperfusion. Circ Res 1990, 67:1453-1461
27. Cai L, Klein JB, Kang YJ: Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J Biol Chem 2000, 275:38957-38960
28. Abel J, de Ruiter N: Inhibition of hydroxyl-radical-generated DNA degradation by metallothionein. Toxicol Lett 1989, 47:191-196
29. Thomas JP, Bachowski GJ, Girotti AW: Inhibition of cell membrane lipid peroxidation by cadmium- and zinc-metallothioneins. Biochim Biophys Acta 1986, 884:448-461
30. Finney JW, Urschel HC, Balla GA, Race GA, Jay BE, Pingree HP, Dorman HL, Mallams JT: Protection of the ischemic heart with DMSO alone or DMSO with hydrogen peroxide. Ann NY Acad Sci 1967, 141:231-241
31. Hatipoglu AR, Temiz E, Yuksel M, Hoscoskun Z, Coskun I, Huseyinova G: The comparison of electron microscopy and scintigraphy in determining the protective effect of dimethylsulphoxide (DMSc) on ischemia/reperfusion injury through Pringle maneuver. Hepatogastroenterology 2001, 48:799-802
32. Yuksel M, Hatipoglu A, Temiz E, Salihoglu YS, Huseyinova G, Berkarda S: The role of hepatobiliary scintigraphy in the evaluation of the protective effects of dimethylsulphoxide in ischaemic/reperfusion injury of liver. Nucl Med Commun 2000, 21:775-780
33. Naganuma A, Satoh M, Imura N: Specific reduction of toxic side effects of Adriamycin by induction of metallothionein in mice, Jpn J Cancer Res 1988, 79:406-411
34. Namikawa K, Okazaki Y, Nishida S, Kimoto S, Akai F, Tomura T, hashimoto S: Changes in myocardial metallothionein on isoproterenol-induced myocardial injury. Yakugaku Zasshi 1993, 113:591-595
35. Sato M, Sasaki M, Hojo H: Tissue-specific induction of metallothionein synthesis by tumor necrosis factor-a. Res Commun Chem Pathol Pharmacol 1992, 75:159-172